10 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
of neurotoxin, non-toxic non-haemagglutinin protein, and haemagglutinin proteins. The active part of the botulinum toxin is the 150 kDa component … for some diseases or when the product may be too inherently toxic to ethically administer to healthy volunteers, the initial human testing is often
425
r3qfnil 0yiig
13 Dec 22
Business combination disclosure
4:26pm
8-K
EX-2.1
i3kiamyzu h3
13 Dec 22
Entry into a Material Definitive Agreement
9:46am
- Prev
- 1
- Next